Artificial Womb Facility Market is segmented By Facility (Bioreactors, Extrauterine Support Devices, Other), By Technology (Neonatal Intensive Care Units (NICUS), Birthing Centres, Others), By Application (Prenatal Care, Neonatal Care), By End-User (Hospitals, Newborn Care Centres, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) – Share, Size, Outlook, And Opportunity Analysis, 2023-2030. The Artificial Womb Facility Market was valued at US$ 285.54 million in 2022 and the total market is forecasted to grow at a CAGR of 8.95% from 2023 to 2030, reaching nearly US$ 520.65 million by 2030.
During surgical operations, anesthesia machines are used to manage blood pressure, discomfort, respiration, blood flow, and heart rate and rhythm. The patient's medical state is produced by the use of anesthesia, which causes a lack of feeling or awareness, making the surgery easier for the surgeons to complete. Ventilators, on the other hand, aid in the management of respiratory disorders such as asthma, COPD, and others.
According to the Pharmanucleus’s newly published report, the global “Intrapartum Monitoring Devices Market” is predicted to grow at a tremendous CAGR of 7 % during the forecast period 2023-2030.
Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!
One of our marquee services We profile relevant start-up companies in the market.
Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.
Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.